Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


Amphion Alliance News (AMP)



Alliance News for Amphion (AMP)


Share Price: 1.50Bid: 1.25Ask: 1.75Change: 0.125 (+9.09%)Riser - Amphion
Spread: 0.50Spread as %: 40.00%Open: 1.375High: 1.50Low: 1.375Yesterday’s Close: 1.375




Amphion Innovations Gets Loan To Tide Itself Over Until Cash Inflows Arrive

Thu, 5th Jun 2014 11:57

LONDON (Alliance News) - Amphion Innovations PLC Thursday said it it had been granted a loan facility by an unnamed institutional lender, which it will use for working capital ahead of expected cash inflows it is set to receive in the next six to 12 months.

The developer of medical and technology businesses said it has already drawn down USD2 million of the new facility, and can draw down up to USD10 million more.

"Amphion has expectations of cash inflows from several different sources over the next six to twelve months and this facility provides the capital we need to bridge to those inflows without incurring excessive dilution," Amphion Chief Executive Richard Morgan said in a statement.

"These funds will enable us to continue to support our IP licensing programme and the further development of our partner companies," he added.

In a statement, the company said the loan is secured by part of its holding in Kromek Group PLC, and can be repaid at its own discretion with cash, Amphion shares, or Kromek shares. Repayment will start on a monthly basis from September 1, with the final payment to be made on June 1 next year.

As part of the loan terms, the lender will receive 8.5 million three-year warrants in Amphion with an exercise price of 4.375 pence per share. It will also get 663,627 three-year simulated warrants at an exercise price of 56.25 pence per share, and if the lender exercises these warrants, Amphion will pay the difference between the exercise price and the Kromek market price.

Amphion is being charged interest at 12% a year on the gross amount. It will also pay 8% of the gross amount as an implementation fee.

Amphion currently has seven partner companies in which it is invested, including digital x-ray systems company Kromek Ltd, software company Axcess International Inc, online energy trading marketplace PrivateMarkets Inc, and clinical research tools company m2m Imaging Corp. It has a 14.82% stake in Kromek.

Amphion Innovations shares were down 4.8% at 2.50 pence Thursday.

By Steve McGrath; stevemcgrath@alliancenews.com; @stevemcgrath1

Copyright 2014 Alliance News Limited. All Rights Reserved.

Alliance News


Related Shares:





WINNERS & LOSERS SUMMARY: Playtech Drops As 2017 Set To Miss Forecasts

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Standard Chartered
[2 Nov '17 10:31]

Amphion Innovations: DataTern's Case Against MicroStrategy Withdrawn

LONDON (Alliance News) - Shares dropped in Amphion Innovations PLC on Thursday as it said that subsidiary DataTern Inc had its case against MicroStrategy Inc and customers dismisse
[2 Nov '17 10:10]

Amphion Innovations Half-Year Net Asset Value And Profit Increases

LONDON (Alliance News) - Capital Market Company Amphion Innovations PLC said Friday its profit rose and net asset value increased in the first half of 2017.Amphion Innovations regi
[29 Sep '17 12:12]

Amphion Innovations Partner Company Agrees Merger With US's Polarean (ALLISS)

LONDON (Alliance News) - Life science and medical business developer Amphion Innovations PLC on Wednesday said its partner company m2m Acquisition Inc has signed a definitive cash
[31 May '17 12:21]

Motif Bio Shares Rise As It Files To List On NASDAQ Market (ALLIPO)

LONDON (Alliance News) - Shares in biopharmaceutical firm Motif Bio PLC rose Wednesday morning after it said it had filed to list American Depositary Shares on the NASDAQ Global Se
[13 Jul '16 09:13]

WINNERS & LOSERS SUMMARY: Poundland Jumps On Steinhoff Takeover Deal

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------Burberry Group, u
[13 Jul '16 10:43]

Amphion Reports Huge Net Asset Value Rise Thanks To Motif Bio

LONDON (Alliance News) - Amphion Innovations PLC Thursday said its net asset value was over five times higher at the end of 2015, boosted by its investment in fellow London-listed
[23 Jun '16 10:01]

Amphion Innovations Agrees Additional Drawdown Of Loan (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC on Friday said it has agreed terms on the additional drawdown of its loan facility.Amphion said it will draw down another USD1.8 mi
[29 Apr '16 16:08]




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.